Merck KGaA (ETR:MRK) Trading Up 0.4% – Should You Buy?

Merck KGaA (ETR:MRK – Get Free Report) shares shot up 0.4% on Thursday . The stock traded as high as €140.30 and last traded at €140.10. Approximately 145,206 shares changed hands during trading, The stock had previously closed at €139.50.

Merck KGaA Trading Up 0.4%

The company has a debt-to-equity ratio of 40.47, a current ratio of 1.51 and a quick ratio of 0.72. The stock’s 50-day moving average is €132.91 and its two-hundred day moving average is €123.66. The company has a market cap of $62.39 billion, a P/E ratio of 23.01, a P/E/G ratio of 2.37 and a beta of 0.82.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.

Further Reading

• Five stocks we like better than Merck KGaA
• Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
• Revving Up Returns: Big Banks Race Through the Rate Plateau
• Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
• Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.